The report offers detailed coverage of Oncology/Cancer Drugs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Oncology/Cancer Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer and Other Cancer Treatment. The most proportion of Oncology Drugs used for Blood Cancer and the proportion in 2017 is 22.74%.
The report forecast global Oncology/Cancer Drugs market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025.
First, this report covers the present status and the future prospects of the global Oncology/Cancer Drugs market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
At the same time, we classify Oncology/Cancer Drugs according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows: By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
Key Companies
Roche
HENGRUI
AstraZeneca
QILU
Sanofi
HANSOH
LUYE
Novartis
GuiZhou YiBai
Lunan
Eli Lilly and Company
Market by Order Type
Antimetabolite
Alkaloid drugs
Hormone
Targeted drug
Platinum-based drugs
Other
Market by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Oncology/Cancer Drugs Market Size Growth Rate by Type (2020-2025)
1.3.2 Antimetabolite
1.3.3 Alkaloid drugs
1.3.4 Hormone
1.3.5 Targeted drug
1.3.6 Platinum-based drugs
1.3.7 Other
1.4 Market Segment by Application
1.4.1 Global Oncology/Cancer Drugs Market Share by Application (2020-2025)
1.4.2 Blood Cancer
1.4.3 Breast Cancer
1.4.4 Gastrointestinal Cancer
1.4.5 Prostate Cancer
1.4.6 Respiratory/Lung Cancer
1.4.7 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology/Cancer Drugs Market Size
2.1.1 Global Oncology/Cancer Drugs Revenue 2015-2025
2.1.2 Global Oncology/Cancer Drugs Sales 2015-2025
2.2 Oncology/Cancer Drugs Growth Rate by Regions
2.2.1 Global Oncology/Cancer Drugs Sales by Regions 2015-2019
2.2.2 Global Oncology/Cancer Drugs Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Oncology/Cancer Drugs Sales by Manufacturers
3.1.1 Oncology/Cancer Drugs Sales by Manufacturers 2015-2019
3.1.2 Oncology/Cancer Drugs Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Oncology/Cancer Drugs Revenue by Manufacturers (2015-2019)
3.2.2 Oncology/Cancer Drugs Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Oncology/Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Oncology/Cancer Drugs Price by Manufacturers
3.4 Key Manufacturers Oncology/Cancer Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Oncology/Cancer Drugs Market
3.6 Key Manufacturers Oncology/Cancer Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Antimetabolite Sales and Revenue (2015-2019)
4.1.2 Alkaloid drugs Sales and Revenue (2015-2019)
4.1.3 Hormone Sales and Revenue (2015-2019)
4.1.4 Targeted drug Sales and Revenue (2015-2019)
4.1.5 Platinum-based drugs Sales and Revenue (2015-2019)
4.1.6 Other Sales and Revenue (2015-2019)
4.2 Global Oncology/Cancer Drugs Sales Market Share by Type
4.3 Global Oncology/Cancer Drugs Revenue Market Share by Type
4.4 Oncology/Cancer Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Oncology/Cancer Drugs Sales by Application
6 United States
6.1 United States Oncology/Cancer Drugs Breakdown Data by Company
6.2 United States Oncology/Cancer Drugs Breakdown Data by Type
6.3 United States Oncology/Cancer Drugs Breakdown Data by Application
7 European Union
7.1 European Union Oncology/Cancer Drugs Breakdown Data by Company
7.2 European Union Oncology/Cancer Drugs Breakdown Data by Type
7.3 European Union Oncology/Cancer Drugs Breakdown Data by Application
8 China
8.1 China Oncology/Cancer Drugs Breakdown Data by Company
8.2 China Oncology/Cancer Drugs Breakdown Data by Type
8.3 China Oncology/Cancer Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Oncology/Cancer Drugs Breakdown Data by Company
9.2 Rest of World Oncology/Cancer Drugs Breakdown Data by Type
9.3 Rest of World Oncology/Cancer Drugs Breakdown Data by Application
9.4 Rest of World Oncology/Cancer Drugs Breakdown Data by Countries
9.4.1 Rest of World Oncology/Cancer Drugs Sales by Countries
9.4.2 Rest of World Oncology/Cancer Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Oncology/Cancer Drugs
10.1.4 Oncology/Cancer Drugs Product Introduction
10.1.5 Roche Recent Development
10.2 HENGRUI
10.2.1 HENGRUI Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Oncology/Cancer Drugs
10.2.4 Oncology/Cancer Drugs Product Introduction
10.2.5 HENGRUI Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Oncology/Cancer Drugs
10.3.4 Oncology/Cancer Drugs Product Introduction
10.3.5 AstraZeneca Recent Development
10.4 QILU
10.4.1 QILU Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Oncology/Cancer Drugs
10.4.4 Oncology/Cancer Drugs Product Introduction
10.4.5 QILU Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Oncology/Cancer Drugs
10.5.4 Oncology/Cancer Drugs Product Introduction
10.5.5 Sanofi Recent Development
10.6 HANSOH
10.6.1 HANSOH Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Oncology/Cancer Drugs
10.6.4 Oncology/Cancer Drugs Product Introduction
10.6.5 HANSOH Recent Development
10.7 LUYE
10.7.1 LUYE Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Oncology/Cancer Drugs
10.7.4 Oncology/Cancer Drugs Product Introduction
10.7.5 LUYE Recent Development
10.8 Novartis
10.8.1 Novartis Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Oncology/Cancer Drugs
10.8.4 Oncology/Cancer Drugs Product Introduction
10.8.5 Novartis Recent Development
10.9 GuiZhou YiBai
10.9.1 GuiZhou YiBai Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Oncology/Cancer Drugs
10.9.4 Oncology/Cancer Drugs Product Introduction
10.9.5 GuiZhou YiBai Recent Development
10.10 Lunan
10.10.1 Lunan Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Oncology/Cancer Drugs
10.10.4 Oncology/Cancer Drugs Product Introduction
10.10.5 Lunan Recent Development
10.11 Eli Lilly and Company
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Oncology/Cancer Drugs Sales Channels
11.2.2 Oncology/Cancer Drugs Distributors
11.3 Oncology/Cancer Drugs Customers
12 Market Forecast
12.1 Global Oncology/Cancer Drugs Sales and Revenue Forecast 2020-2025
12.2 Global Oncology/Cancer Drugs Sales Forecast by Type
12.3 Global Oncology/Cancer Drugs Sales Forecast by Application
12.4 Oncology/Cancer Drugs Forecast by Regions
12.4.1 Global Oncology/Cancer Drugs Sales Forecast by Regions 2020-2025
12.4.2 Global Oncology/Cancer Drugs Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Reports Insights offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Reports Insights assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Reports Insights provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
The report is pretty good as a whole. Especially, the analysis on margin and manufacturing cost is challenging to investigate in general. The team of Reports Insights provided a proper explanation to this. It helped me understand the market well, which leads to our interest in the next marketing report from Reports Insights. I would like to thank the entire team for living up to my expectations in terms of quality & value.
I am completely satisfied with the information given in the report. Report Insights is a value driven company just like us.
Privacy requested , Managing Director
Reports Insights have understood our exact need and Delivered a solution for our requirements. Our experience with them has been fantastic.
Privacy requested, President
Report of Reports Insight has given us the ability to compete with our competitors, every dollar we spend with Reports Insights is worth every penny Reports Insights have given us a robust solution.
